RENEO PHARMACEUTICALS

Updated 12 days ago
Private Limited Company
  • Active - 11136706 (CH)
  • Age: 4 years
  • ID: 49285145/4
18575 Jamboree Rd. Suite 275-S Irvine, CA 92612
• 72110 - Research and experimental development on biotechnology
Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases including mitochondrial diseases with significant unmet medical needs... Reneo is initially developing REN001 in two rare genetic diseases that typically present with myopathy: primary mitochondrial myopathies (PMM), and long-chain fatty acid oxidation disorders (LC-FAOD)... At Reneo Pharmaceuticals, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe' section below.
Also known as: Reneo, RENEO PHARMA LTD, Reneo Pharmaceuticals, Inc.
Registration numbers: 11136706 (CH)
Primary location: Irvine United States
  • 0
  • 0
Interest Score
1
HIT Score
0.33
InvestorRelations

UK Company Data

Company number
11136706
Account category
SMALL
Account ref. day
31
Account ref. month
12
Accounts next due date
2022-09-30
Accounts last made up date
2020-12-31
Returns next due date
2019-02-05
Returns last made up date
N/A
Num. mort. charges
0
Num. mort. outstanding
0
Num. mort. part. satisfied
0
Num. mort. satisfied
0
Num. gen. partners
0
Num. lim. partners
0
Domain
reneopharma.com

Actual
reneopharma.com

IP
141.193.213.10, 141.193.213.11

Status
OK

Category
Company
0 comments Add a comment